HTERT MNS16A polymorphism in breast cancer: a case-control study

Autor: Zagouri, F. Sergentanis, T.N. Gazouli, M. Tsigginou, A. Dimitrakakis, C. Eleutherakis-Papaiakovou, E. Papaspyrou, I. Chrysikos, D. Theodoropoulos, G. Zografos, G.C. Antsaklis, A. Dimopoulos, A.M. Papadimitriou, C.A.

This case-control study aims to investigate the role of HTERT MNS16A polymorphism as a potential risk factors and/or a prognostic marker for breast cancer. 113 consecutive incident cases of histologically confirmed ductal breast cancer and 124 health

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::ba47fb9712a44b43c8c9eef6a663329f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3090451

Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast Cancer

Autor: Stevens, K.N., Vachon, C.M., Lee, A.M., Slager, S., Lesnick, T., Olswold, C., Fasching, P.A., Miron, P., Eccles, D., Carpenter, J.E., Godwin, A.K., Ambrosone, C., Winqvist, R., Brauch, H., Schmidt, M.K., Cox, A., Cross, S.S., Sawyer, E., Hartmann, A., Beckmann, M.W., Schulz-Wendtland, R., Ekici, A.B., Tapper, W.J., Gerty, S.M., Durcan, L., Graham, N., Hein, R., Nickels, S., Flesch-Janys, D., Heinz, J., Sinn, H.P., Konstantopoulou, I., Fostira, F., Pectasides, D., Dimopoulos, A.M., Fountzilas, G., Clarke, C.L., Balleine, R., Olson, J.E., Fredericksen, Z., Diasio, R.B., Pathak, H., Ross, E., Weaver, J., Rudiger, T., Forsti, A., Dunnebier, T., Ademuyiwa, F., Kulkarni, S., Pylkas, K., Jukkola-Vuorinen, A., Ko, Y.D., Van Limbergen, E., Janssen, H., Peto, J., Fletcher, O., Giles, G.G, Baglietto, L., Verhoef, S., Tomlinson, I., Kosma, V.M., Beesley, J., Greco, D., Blomqvist, C., Irwanto, A., Liu, J., Blows, F.M., Dawson, S.J., Margolin, S., Mannermaa, A., Martin, N.G., Montgomery, G.W., Lambrechts, D., Silva, I.D., Severi, G., Hamann, U., Pharoah, P., Easton, D.F., Chang-Claude, J., Yannoukakos, D., Nevanlinna, H., Wang, X.S., Couch, F.J., Consortium, GENICA.

Triple-negative breast cancers are an aggressive subtype of breast cancer with poor survival, but there remains little known about the etiologic factors that promote its initiation and development. Commonly inherited breast cancer risk factors identi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::1f985e8173025ba173368f581c3b1d4c
https://eprints.whiterose.ac.uk/110871/1/nihms-318909.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multicenter phase II trial of first-line irinotecan (CPT-11) and gemcitabine (GMB) in patients with unresectable pancreatic cancer

Autor: Stathopoulos, G., Rigatos, S., Androulakis, N., Souglakos, J., Kouroussis, Ch., Dimopoulos, A.M., Aravantinos, G., Giannakakis, Th., Foutzilas, G., Stathopoulos, J., Georgoulias, V.

Publikováno v: In European Journal of Cancer 2001 37 Supplement 6:S313-S313

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.